Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a cell injection boost hearing restoration? new trial begins

NCT ID NCT07032038

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 33 times

Summary

This early-stage trial tests a new cell therapy called Rincell-1 for adults with certain types of hearing loss who are getting a cochlear implant. The study will compare the safety and effects of receiving the cell injection along with the implant versus the implant alone. About 20 participants will be followed for a year to see if the therapy helps improve nerve function in the ear.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SENSORINEURAL HEARING LOSS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cambridge University Hospital

    Cambridge, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Guy's and St Thomas' Trust

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospitals Birmingham

    Birmingham, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.